Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul;17(3):250-3.
doi: 10.4103/0974-9233.65496.

A prospective, randomized comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab (avastin) in diffuse diabetic macular edema

Maha M Shahin  1 , Rasheed S El-Lakkany
Affiliations

A prospective, randomized comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab (avastin) in diffuse diabetic macular edema

Maha M Shahin et al. Middle East Afr J Ophthalmol. 2010 Jul.

Abstract

Purpose: To compare the functional and anatomical outcomes following intravitreal triamcinolone acetonide vs. intravitreal bevacizumab (Avastin) treatment for diffuse diabetic macular edema.

Materials and methods: IN THIS PROSPECTIVE, RANDOMIZED STUDY, SUBJECTS WERE DIVIDED INTO TWO GROUPS: 24 eyes that received intravitreal injection of 4 mg/0.1 mL triamcinolone acetonide (IVTA group) and 24 eyes received intravitreal injection of 1.25 mg/0.05 mL bevacizumab (IVB group). Changes in best corrected visual acuity (BCVA), intraocular pressure (IOP), baseline fluorescein angiography and optical coherence tomography measurements were evaluated in both groups. Follow-up visits out to three months from baseline are reported.

Results: One month after treatment, baseline foveal thickness decreased from 452 µ to 299 µ in the IVTA group and from 292 µ to 270 µ in the IVB group. BCVA increased by two or more lines in 58.3% of eyes in the IVTA group and there was no similar improvement in the IVB group. In the IVTA group, a transient increase in IOP (27-43 mmHg) occurred in four cases (16.7%), which was successfully controlled with topical medications. There were no complications in the IVB group.

Conclusion: Short term outcomes indicate that intravitreal injection of bevacizumab was not associated with surgical complications compared to triamcinolone acetonide. Triamcinolone acetonide appears to be more effective treatment for diabetic macular edema than bevacizumab.

Keywords: Bevacizumab; Diabetic Macular Edema; Intravitreal Triamcinolone; Retina; Vascular Endothelial Growth Factor.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Optical coherence tomography of a 59-year-old male diabetic with cystoid macular edema A) before and B) three months after IVTA intravitreal triamcinolone acetonide injection
Figure 2
Figure 2
Optical coherence tomography of a 62-year-old female diabetic with diffuse diabetic macular edema A) before and B) three months after intravitreal bevacizumab injection
See this image and copyright information in PMC

References

    1. Klein R, Klein BE, Moss SE. Visual impairment in diabetes. Ophthalmology. 1984;91:1–9. - PubMed
    1. Early Treatment Diabetic Retinopathy Study Research Group. Focal photocoagulation treatment of diabetic macular edema: Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no.19. Arch Ophthalmol. 1995;113:1144–55. - PubMed
    1. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol. 1985;103:1796–806. - PubMed
    1. Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema: Early Treatment Diabetic Retinopathy Study Report Number 2. Ophthalmology. 1987;94:761–74. - PubMed
    1. Lee CM, Olk RJ. Modified grid laser photocoagulation for diffuse diabetic macular edema: Long-term visual results. Ophthalmology. 1991;98:1594–602. - PubMed